John David Finley, CEO, CFO at PALISADE BIO, INC. (PALI), sold 146,798 shares at $2.07 ($303K) on 2026-07-07, disclosed to the SEC on 2026-07-08.
Open-market sale of $303k PALI by CEO, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PALI | BUY | 2024-02-07 | $5K | — | Filing → |
| PALI | BUY | 2024-02-01 | $6K | — | Filing → |
| PALI | BUY | 2023-09-29 | $8K | — | Filing → |